Belinostat approved for use in treating rare lymphoma

Am J Health Syst Pharm. 2014 Aug 15;71(16):1328. doi: 10.2146/news140056.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval*
  • Humans
  • Hydroxamic Acids / adverse effects
  • Hydroxamic Acids / therapeutic use*
  • Lymphoma, T-Cell, Peripheral / drug therapy*
  • Sulfonamides / adverse effects
  • Sulfonamides / therapeutic use*

Substances

  • Hydroxamic Acids
  • Sulfonamides
  • belinostat